Probiotics, Prebiotics and Synbiotics Show Broad Metabolic and Hormonal Benefits in PCOS Meta-Analysis

A large systematic review and meta-analysis of randomized controlled trials reports that prebiotics, probiotics, and synbiotics — collectively termed “biotics” — are associated with improvements across a wide range of metabolic, hormonal, oxidative stress, and inflammatory measures in women with polycystic ovary syndrome (PCOS). The work, published in Reproductive Sciences, combined a GRADE-assessed meta-analysis of twenty randomized controlled trials with an umbrella review of eleven previously published meta-analyses, aiming to give the fullest picture yet of how these supplements affect metabolism and endocrine function in PCOS.

The authors of the new analysis argued that this fragmentation left the field without a comprehensive evaluation of the full metabolic panel and sex hormone profile. To address that gap, the team searched PubMed, Scopus, Cochrane, Web of Science, and Embase systematically, pooling standardized mean differences (SMD) across trials and then comparing their findings against the accumulated evidence in existing meta-analyses.

The pooled estimates pointed to consistent, if modest-to-moderate, benefits on body composition. Biotic supplementation was associated with reduced weight (SMD: −1.21, 95% CI: −2.06 to −0.36), lower body mass index (SMD: −0.77, 95% CI: −1.45 to −0.10), reduced waist circumference (SMD: −0.67, 95% CI: −1.18 to −0.16), and a lower waist-to-hip ratio (SMD: −0.84, 95% CI: −1.52 to −0.15).

Glycemic control also improved. Supplementation was associated with lower fasting plasma glucose (SMD: −0.71, 95% CI: −1.19 to −0.24), reduced fasting insulin (SMD: −0.64, 95% CI: −1.07 to −0.21), and improved insulin resistance as measured by HOMA-IR (SMD: −0.78, 95% CI: −1.24 to −0.32).

The lipid profile shifted favorably as well. Total cholesterol fell (SMD: −0.69, 95% CI: −1.25 to −0.13), along with LDL cholesterol (SMD: −0.71, 95% CI: −1.21 to −0.20) and triglycerides (SMD: −0.53, 95% CI: −0.95 to −0.10), while HDL cholesterol, the protective fraction, rose (SMD: 0.39, 95% CI: 0.19 to 0.60).

Markers of oxidative stress moved in the same beneficial direction. Malondialdehyde, a lipid peroxidation product commonly used as a marker of oxidative damage, decreased (SMD: −0.96, 95% CI: −1.29 to −0.63), while total antioxidant capacity increased (SMD: 0.59, 95% CI: 0.29 to 0.89). Testosterone, the androgen central to many of PCOS’s clinical manifestations, was also reduced with supplementation (SMD: −1.29, 95% CI: −1.98 to −0.68) — one of the largest effect sizes reported in the meta-analysis, though also one with a comparatively wide interval.

The umbrella review, which synthesized eleven existing meta-analyses rather than raw trials, broadly corroborated these results. It concluded that biotics may contribute to improvements in weight, BMI, waist circumference, fasting plasma glucose, insulin, HOMA-IR, the QUICKI insulin sensitivity index, lipid profile, C-reactive protein, the oxidative stress markers MDA and TAC, total testosterone, and the LH/FSH ratio.

Those limitations aside, the scale and breadth of the analysis are its distinguishing feature. Where previous work examined biotics against single outcomes, this review spans anthropometry, glycemia, insulin sensitivity, lipids, oxidative stress, inflammation, and reproductive hormones simultaneously in the same population. The authors conclude that prebiotics, probiotics, or synbiotics “may confer beneficial effects on a range of health outcomes among patients with PCOS” — a measured summary that matches the data.

Subject of Research: Effects of prebiotics, probiotics, and synbiotics on metabolic, hormonal, oxidative stress, and inflammatory outcomes in women with polycystic ovary syndrome

Article Title: Effects of Prebiotics, Probiotics, or Synbiotics on Health Outcomes, Sex Hormones, Oxidative Stress, and Inflammatory Biomarkers in Women with Polycystic Ovary Syndrome: A GRADE Systematic Review, Meta-Analysis of Randomized Controlled Trials, and Umbrella Review

Article References: Dong, Q., Chen, H., Liu, N., Wang, M., & He, Y. (2026). Effects of Prebiotics, Probiotics, or Synbiotics on Health Outcomes, Sex Hormones, Oxidative Stress, and Inflammatory Biomarkers in Women with Polycystic Ovary Syndrome: A GRADE Systematic Review, Meta-Analysis of Randomized Controlled Trials, and Umbrella Review. Reproductive Sciences. https://doi.org/10.1007/s43032-026-02205-5

Image Credits: AI Generated

DOI: 10.1007/s43032-026-02205-5

Keywords: PCOS, probiotics, prebiotics, synbiotics, meta-analysis, systematic review, insulin resistance, testosterone, oxidative stress, lipid profile, women's health, Reproductive Sciences